Analysts are reading Coty Inc.’s preliminary fiscal 2025 first-quarter results and specialty beauty retailer LVMH’s third-quarter report as signs of a US consumer spending slowdown ahead of broader quarterly results unfolding in coming days across the beauty sector.
Bundle Up! Coty, LVMH Quarterly Results Signal US Consumer Spending Chill
Coty Inc.’s preliminary fiscal first-quarter sales growth of 4%-5% like-for-like versus expectations of 6% and LMVH’s third-quarter report showing soft sales of Selective Retailing and Cosmetics & Perfumes signal a slowdown in consumer spending in the US beauty market, analysts agree.
More from Earnings
• By
Coty Inc. reports fiscal second quarter sales slipped 3% on a reported basis to $1.67bn, reflecting further slowing of the mass beauty market, particularly color cosmetics.
• By
L’Oréal Groupe expects total sales in 2025 to beat 4%-4.5% growth anticipated for the overall beauty market, with US population growth, planned innovations boding well across its beauty businesses.
• By
Cincinnati-based P&G reports its antiperspirants/deodorants business is a ‘pocket of strength,’ growing 11% in the US in the fiscal second quarter and helping lift overall beauty sales as skin care stumbles.
New York-based International Flavors & Fragrances, Inc.’s Scent division is undertaking R&D in natural, synthetic chemistry and biotech molecules, says CEO Erik Fyrwald during a third quarter earnings presentation 6 November.
More from HBW Insight
• By
Chinese consumers are now routinely taking supplements for a variety of health reasons, helping to drive up sales of the Swisse Plus+ brand by 20% in 2024.
• By
US FDA Commissioner nominee Martin Makary is being embraced by industry, and Senate Democrats, as a more traditional pick than other Trump Administration nominees, but the Make America Healthy Again agenda still is clearly coming to the agency.
• By
FDA says “extension affords covered entities the additional time necessary to ensure complete coordination across the supply chain in order to fully implement the final rule’s requirements—ultimately providing FDA and consumers with greater transparency and food safety.”